Corvus Pharmaceuticals, Inc.（CRVS）内部人交易：高管与董事近期交易
过去 18 个月，共有 6 位内部人为 Corvus Pharmaceuticals, Inc.（CRVS）报告了 24 笔 Form 4 交易（最近一笔 2026-06-15）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-15 | Moore David Scott | 董事 | 买入 | 21,700 | $250,201 |
| 2026-05-20 | MILLER RICHARD A MD | President and CEO | 买入 | 5,000 | $60,250 |
| 2026-05-20 | MILLER RICHARD A MD | President and CEO | 买入 | 1,932 | $23,203 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $14,550 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $145,500 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $187,500 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $54,150 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $30,000 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $49,050 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $41,100 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $39,000 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $14,850 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 30,000 | $450,000 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $37,350 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $24,600 |
| 2026-01-30 | Thompson Peter A. | 董事 | 买入 | 15,000 | $31,800 |
| 2025-07-01 | Thompson Peter A. | 董事 | 买入 | 1.4M | $4.9M |
| 2025-07-01 | Thompson Peter A. | 董事 | 卖出 | 1.2M | $4.9M |
| 2025-07-01 | ORBIMED ADVISORS LLC | 董事 | 买入 | 1.4M | $4.9M |
| 2025-07-01 | OrbiMed Capital GP V LLC | 董事 | 买入 | 1.4M | $4.9M |
| 2025-07-01 | ORBIMED ADVISORS LLC | 董事 | 卖出 | 1.2M | $4.9M |
| 2025-07-01 | OrbiMed Capital GP V LLC | 董事 | 卖出 | 1.2M | $4.9M |
| 2025-06-06 | Jones William Benton | SVP, Pharmaceutical Development | 买入 | 19,357 | $67,750 |
| 2025-05-09 | MILLER RICHARD A MD | President and CEO | 买入 | 559,073 | $2.0M |
来源：SEC Form 4 申报文件 · 截至 2026-06-15